Cargando…

Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design

BACKGROUND: The German Research Foundation (DFG) and the Federal Ministry of Education and Research (BMBF) initiated large research programs to foster high quality clinical research in the academic area. These investigator initiated trials (IITs) cover important areas of medical research and often g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nury, E., Bischoff, K., Wollmann, K., Nitschke, K., Lohner, S., Schumacher, M., Rücker, G., Blümle, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532587/ https://www.ncbi.nlm.nih.gov/pubmed/33008297 http://dx.doi.org/10.1186/s12874-020-01125-5

Ejemplares similares

Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
por: Blümle, Anette, et al.
Publicado: (2021)

The Costs of Industry-Sponsored Drug Trials in Canada
por: Tran, Dat T., et al.
Publicado: (2019)

Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials
por: Atal, Ignacio, et al.
Publicado: (2015)

Medical Journals, Academia, and Industry-Sponsored Clinical Trials
por: Frighi, Valeria
Publicado: (2005)

Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016)

The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
por: Akpinar, Ilke, et al.
Publicado: (2019)

Carbon footprint of industry-sponsored late-stage clinical trials
por: Mackillop, Neil, et al.
Publicado: (2023)

Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles
por: Blümle, Anette, et al.
Publicado: (2011)

Sponsors’ participation in conduct and reporting of industry trials: a descriptive study
por: Lundh, Andreas, et al.
Publicado: (2012)

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
por: Marti, Stefanie, et al.
Publicado: (2023)

Industry - from sponsor to provider?
por: Griebenow, Reinhard
Publicado: (2017)

Complexity of design in early phase respiratory clinical trials; evaluating impact of primary endpoints and sponsor size
por: Marco-Ariño, Nicolas, et al.
Publicado: (2021)

Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials
por: Djulbegovic, Benjamin, et al.
Publicado: (2013)

Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations
por: Hartmann, M, et al.
Publicado: (2003)

A comparative study to evaluate quality of data documentation between investigator-initiated and pharmaceutical industry-sponsored studies
por: Figer, Brinal H., et al.
Publicado: (2020)

IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
por: Oude Rengerink, Katrien, et al.
Publicado: (2010)

Industry-Sponsored Research: Author's Reply
por: Sotelo, Julio
Publicado: (2006)

523 The Development of an Institutional Study Start-up Tracker for Industry Sponsored Clinical Trials
por: Jones, Derek, et al.
Publicado: (2022)

Economic impact of industry-sponsored clinical trials in inflammatory bowel diseases: Results from the national institute of gastroenterology “Saverio de Bellis”
por: Polignano, Maurizio Gaetano, et al.
Publicado: (2022)

Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects
por: Gryaznov, Dmitry, et al.
Publicado: (2020)

Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials
por: Krohe, Meaghan, et al.
Publicado: (2016)

Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries
por: Ito, Tatsuya
Publicado: (2016)

Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications
por: Marušić, Ana, et al.
Publicado: (2014)

Sponsors’ and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials
por: Perez, Raymond, et al.
Publicado: (2017)

Industry-Sponsored Research: A More Comprehensive Alternative
por: Mansfield, Peter
Publicado: (2006)

Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia
por: Rose, Klaus, et al.
Publicado: (2019)

Reliability of Trial Information Across Registries for Trials With Multiple Registrations: A Systematic Review
por: Speich, Benjamin, et al.
Publicado: (2021)

Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019
por: Gresham, Gillian, et al.
Publicado: (2020)

Impact of Obesity on Postoperative Outcomes following cardiac Surgery (The OPOS study): rationale and design of an investigator-initiated prospective study
por: Aguiar, Christie, et al.
Publicado: (2019)

The Alliance AMBUSH Trial: Rationale and Design
por: Mahajan, Anita, et al.
Publicado: (2022)

The Integrative Migraine Pain Alleviation through Chiropractic Therapy (IMPACT) trial: Study rationale, design and intervention validation
por: Wayne, P.M., et al.
Publicado: (2020)

Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin
por: Vedula, S. Swaroop, et al.
Publicado: (2013)

Changes in key recruitment performance metrics from 2008–2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov
por: Brøgger-Mikkelsen, Mette, et al.
Publicado: (2022)

The role of corruption and unethical behaviour in precluding the placement of industry sponsored clinical trials in sub-Saharan Africa: Stakeholder views
por: Egharevba, Efe, et al.
Publicado: (2016)

Nonindustry-Sponsored Preclinical Studies on Statins Yield Greater Efficacy Estimates Than Industry-Sponsored Studies: A Meta-Analysis
por: Krauth, David, et al.
Publicado: (2014)

Assessment of Duplicate Publication of Chinese-Sponsored Randomized Clinical Trials
por: Jia, Yuanxi, et al.
Publicado: (2020)

A multi-state model analysis of the time from ethical approval to publication of clinical research studies
por: Blümle, Anette, et al.
Publicado: (2020)

An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov
por: Keezhupalat, Shruthi Muralidharan, et al.
Publicado: (2016)

Of Sophists and Spin-Doctors: Industry-Sponsored Ghostwriting and the Crisis of Academic Medicine
por: McHenry, Leemon
Publicado: (2010)

The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research
por: Flick, E Dawn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_34v66gmpgotp92c1f98u6781us